Affiliation:
1. Department of Hematology, Ningbo First Hospital , Ningbo , 315010, Zhejiang , China
2. Department of Hematology, The Affiliated People’s Hospital of Ningbo University , Ningbo , 315040, Zhejiang , China
Abstract
Abstract
This study aimed to assess the feasibility of diagnosing secondary pulmonary fungal infections (PFIs) in patients with hematological malignancies (HM) using computerized tomography (CT) imaging and a support vector machine (SVM) algorithm. A total of 100 patients with HM complicated by secondary PFI underwent CT scans, and they were included in the training group. Concurrently, 80 patients with the same underlying disease who were treated at our institution were included in the test group. The types of pathogens among different PFI patients and the CT imaging features were compared. Radiomic features were extracted from the CT imaging data of patients, and a diagnostic SVM model was constructed by integrating these features with clinical characteristics. Aspergillus was the most common pathogen responsible for PFIs, followed by Candida, Pneumocystis jirovecii, Mucor, and Cryptococcus, in descending order of occurrence. Patients typically exhibited bilateral diffuse lung lesions. Within the SVM algorithm model, six radiomic features, namely the square root of the inverse covariance of the gray-level co-occurrence matrix (square root IV), the square root of the inverse covariance of the gray-level co-occurrence matrix, and small dependency low gray-level emphasis, significantly influenced the diagnosis of secondary PFIs in patients with HM. The area under the curve values for the training and test sets were 0.902 and 0.891, respectively. Therefore, CT images based on the SVM algorithm demonstrated robust predictive capability in diagnosing secondary PFIs in conjunction with HM.
Subject
General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Reference36 articles.
1. Gaudio A, Xourafa A, Rapisarda R, Zanoli L, Signorelli SS, Castellino P. Hematological diseases and osteoporosis. Int J Mol Sci. 2020;21(10):3538.
2. Klein A, Molad Y. Hematological manifestations among patients with rheumatic diseases. Acta Haematol. 2021;144(4):403–12.
3. Liao XY, Qiu KY, Wu RH, Guo SY, Wang J, Huang K, et al. Clinical analysis of 164 children of blood disease complicated with invasive fungal disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27(5):1672–7 (Chinese).
4. Kohn DB. Gene therapy for blood diseases. Curr Opin Biotechnol. 2019;60:39–45.
5. Wagner SJ, Leiby DA, Roback JD. Existing and emerging blood-borne pathogens: Impact on the safety of blood transfusion for the hematology/oncology patient. Hematol Oncol Clin North Am. 2019;33(5):739–48.